| ISIN | LU0851061126 |
|---|---|
| Valor Number | 19899078 |
| Bloomberg Global ID | |
| Fund Name | CIC CH - EQUITY CHF "PRIMUS" AKLB |
| Fund Provider |
Bank CIC (Schweiz) AG
Basel, Switzerland T +41 61 264 12 00 Web: cic.ch |
| Fund Provider | Bank CIC (Schweiz) AG |
| Representative in Switzerland |
CACEIS (Switzerland) SA Nyon Phone: +41 22 360 94 00 |
| Distributor(s) | Bank CIC Schweiz AG |
| Asset Class | Equities |
| EFC Category | |
| Distribution Policy | Accumulation |
| Home Country | Luxembourg |
| Issuing Condition | The fund charges a transaction fee (contribution towards expenses incurred in the investment of new assets) |
| Redemption Condition | The fund charges a transaction fee (contribution towards covering expenses incurred in the sale of assets) |
| Investment Strategy *** | N/A |
| Peculiarities |
| Current Price * | 225.14 CHF | 10.11.2025 |
|---|---|---|
| Previous Price * | 222.68 CHF | 07.11.2025 |
| 52 Week High * | 243.98 CHF | 03.03.2025 |
| 52 Week Low * | 198.96 CHF | 09.04.2025 |
| NAV * | 225.14 CHF | 10.11.2025 |
| Issue Price * | ||
| Redemption Price * | ||
| Closing Price * | ||
| Indicative Minimum Price | ||
| Fund Assets *** | 44,592,162 | |
| Unit/Share Assets *** | 8,141,878 | |
| Trading Information SIX | ||
| YTD Performance | +1.95% |
31.12.2024 - 10.11.2025
31.12.2024 10.11.2025 |
|---|---|---|
| 1 month | -0.25% |
10.10.2025 - 10.11.2025
10.10.2025 10.11.2025 |
| 3 months | +0.04% |
11.08.2025 - 10.11.2025
11.08.2025 10.11.2025 |
| 6 months | -2.06% |
12.05.2025 - 10.11.2025
12.05.2025 10.11.2025 |
| 1 year | -1.13% |
11.11.2024 - 10.11.2025
11.11.2024 10.11.2025 |
| 2 years | +17.59% |
10.11.2023 - 10.11.2025
10.11.2023 10.11.2025 |
| 3 years | +13.52% |
10.11.2022 - 10.11.2025
10.11.2022 10.11.2025 |
| 5 years | +12.48% |
10.11.2020 - 10.11.2025
10.11.2020 10.11.2025 |
| Equity Participation Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Share of Total Fund Assets in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Real Estate Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ADDI | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ADDI Date | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| UBS Group AG Registered Shares | 9.21% | |
|---|---|---|
| Roche Holding AG | 8.38% | |
| Nestle SA | 6.69% | |
| Lonza Group Ltd | 5.69% | |
| Novartis AG Registered Shares | 5.03% | |
| ABB Ltd | 4.60% | |
| Zurich Insurance Group AG | 4.58% | |
| Sika AG | 4.56% | |
| Givaudan SA | 4.34% | |
| Compagnie Financiere Richemont SA Class A | 4.24% | |
| Last data update | 30.09.2025 | |
| TER | |
|---|---|
| TER date | |
| Performance Fee *** | |
| PTR | |
| Max. Management Fee *** | 1.50% |
| Ongoing Charges *** | |
|
SRRI ***
|
|
| SRRI date *** | 31.10.2025 |